The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
AstraZeneca
Arvinas Inc.
University of Nebraska
Seagen Inc.
Cancer Research UK
City of Hope Medical Center
University of Southern California
Elicio Therapeutics
TransThera Sciences (Nanjing), Inc.
Instituto do Cancer do Estado de São Paulo
Elevation Oncology